Molecular diagnostics company DiaCarta has developed a novel test to detect the newest COVID-19 Omicron variant, based on its proprietary XNA technology. This new multiplex qPCR-based test—QuantiVirus SARS-CoV-2 Variant Detection Test—screens for the SARS-CoV-2 virus and simultaneously identifies and differentiates all the new mutating COVID-19 variants including the Alpha, Beta, Gamma, Delta, Delta Plus, Epsilon, […]

US-based molecular diagnostics company DiaCarta has developed a new test to detect the new emerging Covid-19 variant, Omicron. The new multiplex qPCR-based test named QuantiVirus SARS-CoV-2 Variant Detection is based on DiaCarta’s proprietary XNA technology. It is designed to identify the SARS-CoV-2 virus and then distinguish various mutating variants. The company has secured CE/IVD marking and will […]

November 30, 2021 — Immunexpress’ SeptiCyte Rapid fully automated diagnostic tool has been granted 510(k) clearance from the U.S. Food and Drug Administration (FDA). The test can aid in the diagnosis of sepsis in one hour for patients suspected of having the illness. SeptiCyte Rapid uses reverse transcription polymerase chain reaction to quantify directly from blood […]